Non-stenosing carotid artery plaques in embolic stroke of undetermined source: a retrospective analysis.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 08 08 2022
accepted: 21 09 2022
pubmed: 28 9 2022
medline: 10 1 2023
entrez: 27 9 2022
Statut: ppublish

Résumé

We aim to identify the association between high-risk carotid plaques and their laterality to stroke in ESUS patient population. We also discuss recurrent stroke events and their laterality to the index stroke. This was a retrospective study. We reviewed data for patients with ESUS between June 20, 2016, and June 20, 2021. Using computed tomography angiography, we analyzed plaque features that are associated with ESUS, and then, we identified the recurrent stroke events and characterized lateralization to the index stroke. Out of 1779 patients with cryptogenic ischemic stroke, we included 152 patients who met the criteria for ESUS. High-risk plaque features were found more often ipsilateral to the stroke side when compared contralaterally: plaque ulceration (19.08% vs 5.26%, p < .0001), plaque thickness > 3 mm (19.08% vs 7.24%, p = 0.001), and plaque length > 1 cm (13.16% vs 5.92%, p = 0.0218). There was also a significant difference in plaque component in which both components (soft and calcified) and only soft plaques were more prevalent ipsilaterally (42.76% vs 23.68% and 17.76% vs 9.21%, respectively, p < .0001). Of the 152 patients, 17 patients were found to have a recurrent stroke event, and 47% (n = 8) had an ipsilateral stroke to the index event. Moreover, stroke was bilateral in 41% of the patients (n = 7), and contralateral in 12% (n = 2). High-risk plaque features studied here were more prevalent ipsilaterally to the stroke side in ESUS than contralaterally. Multicenter studies are needed to form precise prediction models and scoring systems to help guide treatment, i.e., choice of medical therapy and/or revascularization.

Sections du résumé

BACKGROUND BACKGROUND
We aim to identify the association between high-risk carotid plaques and their laterality to stroke in ESUS patient population. We also discuss recurrent stroke events and their laterality to the index stroke.
METHODS METHODS
This was a retrospective study. We reviewed data for patients with ESUS between June 20, 2016, and June 20, 2021. Using computed tomography angiography, we analyzed plaque features that are associated with ESUS, and then, we identified the recurrent stroke events and characterized lateralization to the index stroke.
RESULTS RESULTS
Out of 1779 patients with cryptogenic ischemic stroke, we included 152 patients who met the criteria for ESUS. High-risk plaque features were found more often ipsilateral to the stroke side when compared contralaterally: plaque ulceration (19.08% vs 5.26%, p < .0001), plaque thickness > 3 mm (19.08% vs 7.24%, p = 0.001), and plaque length > 1 cm (13.16% vs 5.92%, p = 0.0218). There was also a significant difference in plaque component in which both components (soft and calcified) and only soft plaques were more prevalent ipsilaterally (42.76% vs 23.68% and 17.76% vs 9.21%, respectively, p < .0001). Of the 152 patients, 17 patients were found to have a recurrent stroke event, and 47% (n = 8) had an ipsilateral stroke to the index event. Moreover, stroke was bilateral in 41% of the patients (n = 7), and contralateral in 12% (n = 2).
CONCLUSION CONCLUSIONS
High-risk plaque features studied here were more prevalent ipsilaterally to the stroke side in ESUS than contralaterally. Multicenter studies are needed to form precise prediction models and scoring systems to help guide treatment, i.e., choice of medical therapy and/or revascularization.

Identifiants

pubmed: 36166175
doi: 10.1007/s10072-022-06425-w
pii: 10.1007/s10072-022-06425-w
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-252

Informations de copyright

© 2022. Fondazione Società Italiana di Neurologia.

Références

Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC et al (1999) The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke 30(9):1751–1758. https://doi.org/10.1161/01.str.30.9.1751
doi: 10.1161/01.str.30.9.1751
(1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351(9113):1379–87. PMID: 9593407
Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ (2009) Continuous electroencephalography in the medical intensive care unit. Crit Care Med 37(6):2051–2056. https://doi.org/10.1097/CCM.0b013e3181a00604
doi: 10.1097/CCM.0b013e3181a00604
Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR et al (2003) Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361(9352):107–116. https://doi.org/10.1016/s0140-6736(03)12228-3
doi: 10.1016/s0140-6736(03)12228-3
Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13(4):429–438. https://doi.org/10.1016/s1474-4422(13)70310-7
doi: 10.1016/s1474-4422(13)70310-7
Hyafil F, Schindler A, Sepp D, Obenhuber T, Bayer-Karpinska A, Boeckh-Behrens T et al (2016) High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging. Eur J Nucl Med Mol Imaging 43(2):270–279. https://doi.org/10.1007/s00259-015-3201-8
doi: 10.1007/s00259-015-3201-8
Altaf N, Daniels L, Morgan PS, Auer D, MacSweeney ST, Moody AR et al (2008) Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg 47(2):337–342. https://doi.org/10.1016/j.jvs.2007.09.064
doi: 10.1016/j.jvs.2007.09.064
Singh N, Moody AR, Panzov V, Gladstone DJ (2018) Carotid intraplaque hemorrhage in patients with embolic stroke of undetermined source. J Stroke Cerebrovasc Dis 27(7):1956–1959. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.02.042
doi: 10.1016/j.jstrokecerebrovasdis.2018.02.042
Kamtchum-Tatuene J, Nomani AZ, Falcione S, Munsterman D, Sykes G, Joy T et al (2021) Non-stenotic carotid plaques in embolic stroke of unknown source. Front Neurol 12:719329. https://doi.org/10.3389/fneur.2021.719329
doi: 10.3389/fneur.2021.719329
Kasner SE, Lynn MJ, Chimowitz MI, Frankel MR, Howlett-Smith H, Hertzberg VS et al (2006) Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 67(7):1275–1278. https://doi.org/10.1212/01.wnl.0000238506.76873.2f
doi: 10.1212/01.wnl.0000238506.76873.2f
Gupta A, Gialdini G, Lerario MP, Baradaran H, Giambrone A, Navi BB et al (2015) Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke. J Am Heart Assoc 4(6):e002012. https://doi.org/10.1161/jaha.115.002012
doi: 10.1161/jaha.115.002012
Gupta A, Gialdini G, Giambrone AE, Lerario MP, Baradaran H, Navi BB et al (2016) Association between nonstenosing carotid artery plaque on MR angiography and acute ischemic stroke. JACC Cardiovasc Imaging 9(10):1228–1229. https://doi.org/10.1016/j.jcmg.2015.12.004
doi: 10.1016/j.jcmg.2015.12.004
Acampa M, Lazzerini PE, Manfredi C, Guideri F, Tassi R, Domenichelli C et al (2020) Non-stenosing carotid atherosclerosis and arterial stiffness in embolic stroke of undetermined source. Front Neurol 11:725. https://doi.org/10.3389/fneur.2020.00725
doi: 10.3389/fneur.2020.00725
Knight-Greenfield A, Quitlong Nario JJ, Vora A, Baradaran H, Merkler A, Navi BB et al (2019) Associations between features of nonstenosing carotid plaque on computed tomographic angiography and ischemic stroke subtypes. J Am Heart Assoc 8(24):e014818. https://doi.org/10.1161/jaha.119.014818
doi: 10.1161/jaha.119.014818
Watase H, Canton G, Sun J, Zhao X, Hatsukami TS, Yuan C (2019) Four different carotid atherosclerotic behaviors based on luminal stenosis and plaque characteristics in symptomatic patients: an in vivo study. Diagnostics (Basel) 9(4):137. https://doi.org/10.3390/diagnostics9040137
doi: 10.3390/diagnostics9040137
Demarco JK, Ota H, Underhill HR, Zhu DC, Reeves MJ, Potchen MJ et al (2010) MR carotid plaque imaging and contrast-enhanced MR angiography identifies lesions associated with recent ipsilateral thromboembolic symptoms: an in vivo study at 3T. AJNR Am J Neuroradiol 31(8):1395–1402. https://doi.org/10.3174/ajnr.A2213
doi: 10.3174/ajnr.A2213
Saba L, Saam T, Jäger HR, Yuan C, Hatsukami TS, Saloner D et al (2019) Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol 18(6):559–572. https://doi.org/10.1016/s1474-4422(19)30035-3
doi: 10.1016/s1474-4422(19)30035-3
Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW et al (2002) Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 105(2):181–185. https://doi.org/10.1161/hc0202.102121
doi: 10.1161/hc0202.102121
Gupta A, Baradaran H, Kamel H, Pandya A, Mangla A, Dunning A et al (2014) Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis. Stroke 45(3):740–745. https://doi.org/10.1161/strokeaha.113.003882
doi: 10.1161/strokeaha.113.003882
Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, Saqqur M, Shuaib A, Jickling GC (2020) Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 77(12):1524–1535. https://doi.org/10.1001/jamaneurol.2020.2658
doi: 10.1001/jamaneurol.2020.2658

Auteurs

Ammar Jumah (A)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA. ajumah1@hfhs.org.

Hassan Aboul Nour (H)

Department of Vascular Neurology, Emory University School of Medicine, Atlanta, GA, USA.

Osama Intikhab (O)

Department of Neuroradiology, Henry Ford Hospital, Detroit, MI, USA.

Omar Choudhury (O)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Karam Gagi (K)

Department of Neurology, Sparrow Hospital, Lansing, MI, USA.

Michael Fana (M)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Hisham Alhajala (H)

Department of Vascular Neurology, University of Toledo, Toledo, OH, USA.

Mohammad Alkhoujah (M)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Owais K Alsrouji (OK)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Lara Eltous (L)

Jordan University of Science and Technology, Amman, Jordan.

Lonni Schultz (L)

Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.

Katie Latack (K)

Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.

Megan Brady (M)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Alex Chebl (A)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Horia Marin (H)

Department of Neuroradiology, Henry Ford Hospital, Detroit, MI, USA.

Daniel Miller (D)

Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH